Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain [1]

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 12, 2000, Pages 3481-3482

  Garcia Rey C ^a   Aguilar, L ^a   Baquero, F ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SPAIN; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; GENE FREQUENCY; HUMANS; MICROBIAL SENSITIVITY TESTS; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 0034426112     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.12.3481-3482.2000     Document Type: Letter

References (4)

1. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
2. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
3. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: Update (1990 to 1996)